Community-based management of gastrointestinal symptoms at end-of-life in scleroderma using subcutaneous medication: a case report

This case illustrates the safe and effective use of subcutaneous omeprazole for managing upper gastrointestinal symptoms at the end of life in a community setting. It supports the role of flexible prescribing and individualised care to respect patient preferences. Due the unpredictable physiology of people at the end-of-life and the challenges in palliative care research, case reports and expert opinion remain vital evidence for clinical practice.